DeviceSignal · Recall classified

Nuclein LLC

FDA classified a device recall on 2026-08-03 · Class II · Z-2861-2026

EventRecall classified
Effective2026-08-03
ClassificationClass II

On 2026-08-03 the FDA classified a device recall from Nuclein LLC as Class II. Product: Brand Name: DASH Rapid PCR Instrument Product Name: DASH Rapid PCR Instrument…. Recall Z-2861-2026. The firm initiated it on 2025-06-25. This reports the classification FDA published on that date.

Reported facts

Recall number
Z-2861-2026
Classification
Class II
Classified on
2026-08-03
Initiated on
2025-06-25
Firm
Nuclein LLC
Reason
Due to a software issue which may result in false co-infection (e.g., Positive for Flu A, when SARS-CoV-2 is present).
Product
Brand Name: DASH Rapid PCR Instrument Product Name: DASH Rapid PCR Instrument Model/Catalog Number: SG-0002 Software Version: 6.0.2 Product Description: The DASH¿ Rapid PCR Instrument (DASH Instrument) is an automated, fluorescence-based, reverse-transcription polymerase chain reaction (RT-PCR) instrument that extracts specimens and performs nucleic acid amplified tests (NAAT) in DASH test cartridges for the qualitative detection of infectious diseases. The DASH Instrument is intended for use in conjunction with DASH Rapid PCR System tests to aid in the diagnosis of infectious diseases. Component: No.

Every field above is as fda_device_enforcement published it. Nothing on this page is our interpretation.

Provenance

Source
fda_device_enforcement
Source record
Z-2861-2026
Snapshot hash
ab5ada73bf212eb52a548aab0968a0fcee42807c61b0350e60e24bb6e2beed72
Source URL
https://download.open.fda.gov/device/enforcement/device-enforcement-0001-of-0001.json.zip
Observed
2026-09-08T16:22:09.483Z
Transform
fda_device_enforcement_to_recall v1
Event rule
fda_device_recall_classified v1
Event key
9afa111fd4abb6f70dd9fc17f5841821d88e72e023fb185dc52d20ed57c4ea91
Signal type
device_recall.classified

Source terms that apply

More DeviceSignal signals What DeviceSignal is

Data provided by the U.S. Food and Drug Administration (https://open.fda.gov)